Sisram Medical

Alma, a Sisram Medical company, is a global leader, providing medical grade treatments for clinical aesthetic indications.

Sisram’s global dental business line brings together Copulla’s end-to-end digital dentistry service and a world-leading standard dental lab.

Sisram’s injectables operation offers skin boosters, dermal facial fillers and soon – a new generation of toxins and fat dissolving .

LMNT, is a personal care brand, a part of Sisram Medical's consumer wellness ecosystem. LMNT provide at-home skin rejuvenation treatment.

Sisram Medical Accelerates DAXXIFY Commercialization in Mainland China

Sisram’s management team oversees operations aligned with strategic guidelines.

Sisram Medical Ltd specializes in medical aesthetic solutions, including Energy-Based Devices, injectables, diagnostics, and complementary products, with over 25 years of experience.

Sisram Medical, a global consumer wellness eco-system, a part of Fosun Pharma Med-Tech group. Sisram is listed on the HKEX main board.

Headquarters: Ofek Building 15 HaHarash Street 18, Industrial Park, Caesarea, 3079895 Israel

Sisram Medical - Enhancing Quality of Life. Sisram is a global consumer wellness group, part of Fosun Pharma.

Sisram Medical plans to repurchase up to 1% of its total issued shares through open-market transactions. The company aims to optimize shareholder value by reducing its outstanding share count. The repurchase program reflects a strategic move to enhance financial flexibility and return value to investors.

Oct 2026PR NewswireNews article

Sisram Medical achieves **US$365.3 million in revenue** for 2025, marking a **4.7% year-over-year increase**. The company’s financial performance reflects steady expansion in its core operations. Sisram Medical specializes in medical technologies and solutions, including imaging and diagnostic systems.

Mar 2026PR NewswireNews article

Lior Dayan steps down as CEO of Alma after eight years and transitions to Chairman of Sisram Medical. Eyal Ben David takes over as Alma’s new Chief Executive Officer, succeeding Dayan’s tenure.

Dec 2025PR NewswireNews article

Sisram Medical reports double-digit revenue growth in Q3 2025, driven by strong year-on-year increases in new orders. Demand remains robust in key markets including China, South Korea, and Thailand, fueling momentum across core businesses.

Oct 2025PR NewswireNews article